RIVERSEDGE ADVISORS, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1787663 Wilmington, DE

Position in REGN

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$243,180

-$34,197 QoQ

Shares Held

390

+8.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#994

of 1,322 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RIVERSEDGE ADVISORS, LLC holds $1,173,687 across 4 Biotechnology names. REGN ranks #2 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	993	$493,252
2	REGN	Regeneron Pharmaceuticals, Inc. This page	390	$243,180
3	INCY	Incyte Corp	2,053	$232,728
4	EXEL	Exelixis, Inc.	3,759	$204,527

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$243,180	390	+8.6%	Shares	Sole	2026-07-16
2026-03-31	$277,377	359	-3.2%	Shares	Sole	2026-04-16
2025-12-31	$286,363	371	—	Shares	Sole	2026-01-07
No filing history on record for this holder in this stock.